EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia
Alzamend Neuro Inc (NASDAQ: ALZN) has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002.
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
SEC Goes After ‘MrZackMorris,’ ‘Stock Sniper’ For Alleged Fraud
Eight people connected to Atlas Trading, a Discord-based community, have been named in a complaint filed by the Securities and Exchange Commission (SEC).
Co-founders of the forum, podcasters, and YouTubers are accused of stock manipulation.
LIVE: Alzamend Neuro CEO Live Now On Fox Business
Watch Fox Business Network (FBN) Free 24/7 - WatchNewsLive.tv
WaveDancer And 1 Other Stock Under $2 Insiders Are Aggressively Buying
The Dow Jones dropped by more than 600 points on Friday. Investors, meanwhile, focused on some notable insider trades.
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Alzamend Neuro Adds Healthy Subjects to Ongoing Mid-Stage Alzheimer’s Trial
Alzamend Neuro Inc (NASDAQ:ALZN) has dosed its first healthy adult subject in its Phase 2A multiple ascending dose (MAD) study of…